Antibodies in Repeated Influenza Vaccination (ARIVA) Study

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Vaccine Response Impaired
Interventions
BIOLOGICAL

Influenza Vaccination

Only subjects vaccinated against influenza will be enrolled. The study itself is observational

Trial Locations (1)

Unknown

University Hospital Basel, Basel

All Listed Sponsors
collaborator

University of Oslo

OTHER

collaborator

University of Oxford

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT04059991 - Antibodies in Repeated Influenza Vaccination (ARIVA) Study | Biotech Hunter | Biotech Hunter